Literature DB >> 8622767

A cortical neuropeptide with neuronal depressant and sleep-modulating properties.

L de Lecea1, J R Criado, O Prospero-Garcia, K M Gautvik, P Schweitzer, P E Danielson, C L Dunlop, G R Siggins, S J Henriksen, J G Sutcliffe.   

Abstract

Acetylcholine (ACh) plays a key role in the transitions between the different phases of sleep: Slow-wave sleep requires low ACh concentrations in the brain, whereas rapid-eye-movement (REM) sleep is associated with high levels of ACh. Also, these phases of sleep are differentially sensitive to a number of endogenous neuropeptides and cytokines, including somatostatin, which has been shown to increase REM sleep without significantly affecting other phases. Here we report the cloning and initial characterization of cortistatin, a neuropeptide that exhibits strong structural similarity to somatostatin, although it is the product of a different gene. Administration of cortistatin depresses neuronal electrical activity but, unlike somatostatin, induces low-frequency waves in the cerebral cortex and antagonizes the effects of acetylcholine on hippocampal and cortical measures of excitability. This suggests a mechanism for cortical synchronization related to sleep.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622767     DOI: 10.1038/381242a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  63 in total

1.  Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.

Authors:  M Schreff; S Schulz; M Händel; G Keilhoff; H Braun; G Pereira; M Klutzny; H Schmidt; G Wolf; V Höllt
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 2.  Open-system approaches to gene expression in the CNS.

Authors:  J G Sutcliffe
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

3.  Somatostatin analogues: are they analogues of somatostatin?

Authors:  R Deghenghi
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

4.  Cortistatin is expressed in a distinct subset of cortical interneurons.

Authors:  L de Lecea; J A del Rio; J R Criado; S Alcántara; M Morales; P E Danielson; S J Henriksen; E Soriano; J G Sutcliffe
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

5.  Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Authors:  Elena Gonzalez-Rey; Nieves Varela; Amir F Sheibanie; Alejo Chorny; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

6.  Growth hormone-inhibiting activity of cortistatin in the rat.

Authors:  R Deghenghi; R Avallone; A Torsello; G Muccioli; E Ghigo; V Locatelli
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

7.  Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides.

Authors:  H Tostivint; I Lihrmann; C Bucharles; D Vieau; Y Coulouarn; A Fournier; J M Conlon; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

8.  Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin.

Authors:  P Dournaud; H Boudin; A Schonbrunn; G S Tannenbaum; A Beaudet
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

9.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

10.  Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity.

Authors:  Nicolas Chartrel; Cynthia Dujardin; Youssef Anouar; Jérôme Leprince; Annick Decker; Stefan Clerens; Jean-Claude Do-Régo; Frans Vandesande; Catherine Llorens-Cortes; Jean Costentin; Jean-Claude Beauvillain; Hubert Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.